| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.064 | 14.231 | 15.188 | 19.507 | 14.391 | 19.550 | 19.866 | 15.890 | 53.401 | 103.195 |
| Total Income - EUR | 13.064 | 14.232 | 15.188 | 19.508 | 14.391 | 34.022 | 39.677 | 33.512 | 87.769 | 126.315 |
| Total Expenses - EUR | 11.440 | 14.452 | 14.091 | 18.794 | 14.164 | 32.242 | 37.688 | 32.206 | 80.667 | 122.467 |
| Gross Profit/Loss - EUR | 1.625 | -220 | 1.097 | 714 | 228 | 1.780 | 1.989 | 1.306 | 7.102 | 3.848 |
| Net Profit/Loss - EUR | 1.233 | -471 | 944 | 517 | 83 | 1.453 | 1.592 | 977 | 6.224 | 59 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 4 | 5 |
Check the financial reports for the company - Ali Ginmed Andre Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 755 | 1.111 | 1.251 | 866 | 5.428 | 33.518 | 34.241 | 52.457 |
| Current Assets | 3.986 | 6.204 | 7.690 | 16.192 | 5.217 | 6.523 | 8.060 | 10.263 | 21.045 | 15.069 |
| Inventories | 2 | 1.061 | 317 | 0 | 0 | 0 | 123 | 528 | 928 | 874 |
| Receivables | 953 | 3.689 | 1.260 | 4.750 | 1.629 | 3.045 | 6.053 | 6.576 | 14.633 | 8.264 |
| Cash | 3.031 | 1.455 | 6.113 | 11.442 | 3.588 | 3.479 | 1.883 | 3.160 | 5.483 | 5.931 |
| Shareholders Funds | 2.007 | 1.516 | 2.434 | 2.907 | 2.933 | 4.330 | 5.827 | 6.821 | 13.025 | 13.010 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.978 | 5.387 | 8.028 | 15.869 | 16.139 | 12.116 | 8.692 | 38.914 | 42.261 | 54.516 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ali Ginmed Andre Srl